Iovance Biotherapeutics (IOVA) Asset Writedowns and Impairment (2011 - 2026)
Iovance Biotherapeutics (IOVA) posted Asset Writedowns and Impairment of $3.31 million for Q2 2026, down 60.2% from $8.32 million a year earlier.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Asset Writedowns and Impairment (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Asset Writedowns and Impairment at Iovance Biotherapeutics was $7.9 million, down 49.6% year-over-year; for FY2025, it came in at $13.4 million, up 82.2% from FY2024.
- Annual Asset Writedowns and Impairment shows a three-year compound annual growth rate of 223.2% (FY2022 to FY2025).
- In prior years, Iovance Biotherapeutics' Asset Writedowns and Impairment was $7.36 million in FY2024 and $397,000 in FY2022.
- Quarterly Asset Writedowns and Impairment has run from a low of -$506,000 in Q1 2026 to a high of $8.32 million in Q2 2025 over five years.
- According to Business Quant data, Asset Writedowns and Impairment for the three prior quarters was -$506,000 (Q1 2026), $3.7 million (Q4 2025) and $1.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Iovance Biotherapeutics | 4.98 Bn | 3.77 Bn | 55.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.31 Mn |
| Mar 31, 2026 | -506,000.00 |
| Dec 31, 2025 | 3.70 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 8.32 Mn |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 7.36 Mn |
| Dec 31, 2022 | 83,000.00 |
| Mar 31, 2022 | 314,000.00 |
| Dec 31, 2011 | 160,036.00 |
API Access
Iovance Biotherapeutics Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();